机构:[1]MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China[2]Artificial Intelligence Unit, Department of Medical Equipment, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China[3]Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China大德路总院外科大德路总院外一科广东省中医院[4]Department of Hepatology and Infection, Sir Run Run Shaw Hospital, Affiliated with School of Medicine, Zhejiang University, Hangzhou, China[5]Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China[6]Hepatology Unit, Zengcheng Branch, Nanfang Hospital, Southern Medical University, Guangzhou, China[7]Department of Hepatology, Tianjin Second People’s Hospital, Tianjin, China[8]Department of Liver Diseases, Hangzhou Normal University Affiliated Hospital, Hangzhou, China[9]Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China[10]Southampton National Institute for Health and Care Research Biomedical Research Centre, University Hospital Southampton & University of Southampton, Southampton General Hospital, Southampton, UK[11]Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Verona, Verona, Italy[12]Department of Pathology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China[13]Department of Nutrition, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China[14]Institute of Hepatology, Wenzhou Medical University, Wenzhou, China
Background: There is an unmet need for accurate non-invasive methods to diagnose non-alcoholic steatohepatitis (NASH). Since impedance-based measurements of body composition are simple, repeatable and have a strong association with non-alcoholic fatty liver disease (NAFLD) severity, we aimed to develop a novel and fully automatic machine learning algorithm, consisting of a deep neural network based on impedance-based measurements of body composition to identify NASH [the bioeLectrical impEdance Analysis foR Nash (LEARN) algorithm].Methods: A total of 1,259 consecutive subjects with suspected NAFLD were screened from six medical centers across China, of which 766 patients with biopsy-proven NAFLD were included in final analysis. These patients were randomly subdivided into the training and validation groups, in a ratio of 4:1. The LEARN algorithm was developed in the training group to identify NASH, and subsequently, tested in the validation group.Results: The LEARN algorithm utilizing impedance-based measurements of body composition along with age, sex, pre-existing hypertension and diabetes, was able to predict the likelihood of having NASH. This algorithm showed good discriminatory ability for identifying NASH in both the training and validation groups [area under the receiver operating characteristics (AUROC): 0.81, 95% CI: 0.77-0.84 and AUROC: 0.80, 95% CI: 0.73-0.87, respectively]. This algorithm also performed better than serum cytokeratin-18 neoepitope M30 (CK-18 M30) level or other non-invasive NASH scores (including HAIR, ION, NICE) for identifying NASH (P value <0.001). Additionally, the LEARN algorithm performed well in identifying NASH in different patient subgroups, as well as in subjects with partial missing body composition data.Conclusions: The LEARN algorithm, utilizing simple easily obtained measures, provides a fully automated, simple, non-invasive method for identifying NASH.
基金:
National Natural Science Foundation of China [82070588]; High Level Creative Talents from Department of Public Health in Zhejiang Province [S2032102600032]; Project of New Century 551 Talent Nurturing in Wenzhou; University School of Medicine of Verona, Verona, Italy; Southampton NIHR Biomedical Research Centre [IS-BRC-20004]
第一作者机构:[1]MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
共同第一作者:
通讯作者:
通讯机构:[1]MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China[9]Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China[14]Institute of Hepatology, Wenzhou Medical University, Wenzhou, China[*1]MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
推荐引用方式(GB/T 7714):
Li Gang,Zheng Tian-Lei,Chi Xiao-Ling,et al.LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis[J].HEPATOBILIARY SURGERY AND NUTRITION.2023,12(4):507-+.doi:10.21037/hbsn-21-523.
APA:
Li, Gang,Zheng, Tian-Lei,Chi, Xiao-Ling,Zhu, Yong-Fen,Chen, Jin-Jun...&Zheng, Ming-Hua.(2023).LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis.HEPATOBILIARY SURGERY AND NUTRITION,12,(4)
MLA:
Li, Gang,et al."LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis".HEPATOBILIARY SURGERY AND NUTRITION 12..4(2023):507-+